Sanofi-Aventis: Aiming to Be Our “360-Degree Diabetes Partner”
Insulin maker Sanofi-Aventis took a big hit last year with the Lantus-cancer scare. But that hasn’t stopped them from charging ahead in diabetes care. According to industry observers, the company’s new US Diabetes unit, fueled by a recent “acquisition binge,” is gearing up to “turn the diabetes world upside-down” with a full set of new offerings to help doctors help patients achieve better outcomes. Sounds intriguing!
I caught up last week with Dennis Urbaniak, Sanofi’s…